A PHASE1/2 CLINICAL TRIAL OF VELIPARIB (ABT-888) AND RADIATION FOLLOWED BY MAINTENANCE THERAPY WITH VELIPARIB AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A PEDIATRIC BRAIN TUMOR CONSORTIUM INTERIM REPORT OF PHASE II STUDY

被引：0
|
作者：
Baxter, Patricia [1 ]
Su, Jack [1 ]
Li, Xiao-nan [1 ]
Thomas, Arzu Onar [2 ]
Billups, Catherine [2 ]
Thompson, Patrick [3 ]
Poussaint, Tina [4 ]
McKeegan, Evelyn [5 ]
Wan, Xia [5 ]
Ansell, Peter [5 ]
Giranda, Vincent [5 ]
Paulino, Arnold [6 ]
Kilburn, Lindsay [7 ]
Qaddoumi, Ibrahim [8 ]
Broniscer, Alberto [8 ]
Blaney, Susan [1 ]
Boyett, James [2 ]
Fouladi, Maryam [1 ]
机构：
[1] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[2] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Univ N Carolina, North Carolina Childrens Hosp, Chapel Hill, NC USA
[4] Childrens Hosp Boston, Boston, MA USA
[5] AbbVie, Abbvie Pk, IL USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Childrens Natl Med Ctr, Washington, DC 20010 USA
[8] St Jude Res Hosp, Memphis, TN USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EPT-15
引用
收藏
页码：27 / 27
页数：1
相关论文
共 36 条
  • [21] Phase II trial of single agent PARP inhibitor ABT-888 (veliparib [vel]) followed by postprogression therapy of vel with carboplatin (carb) in patients (pts) with stage BRCA-associated metastatic breast cancer (MBC): California Cancer Consortium trial PHII-96
    Somlo, George
    Frankel, Paul Henry
    Luu, Thehang H.
    Ma, Cynthia
    Arun, Banu
    Garcia, Agustin
    Cigler, Tessa
    Cream, Leah
    Harvey, Harold A.
    Sparano, Joseph A.
    Nanda, Rita
    Chew, Helen K.
    Moynihan, Timothy Jerome
    Vandat, Linda T.
    Goetz, Matthew P.
    Hurria, Arti
    Mortimer, Joanne E.
    Gandara, David R.
    Chen, Alice
    Weitzel, Jeffrey N.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] PHASE IB CLINICAL TRIAL ASSESSING SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF ALOCELYVIR (ALLOGENEIC MESENCHYMAL CELLS plus ONCOLYTIC ADENOVIRUS) COMBINED WITH RADIOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Lassaletta, Alvaro
    Vazquez-Gomez, Felisa
    Rubio, Alba
    Moreno-Carrasco, Jose Luis
    Sansegundo, Carmen Gonzalez
    Gonzalez-Murillo, Africa
    Horcajo-Morera, Beatriz
    Bautista, Francisco
    Garcia-Aguilera, Gonzalo
    Castillo, Ana
    Solis, Ines
    Borrego, Pedro
    Llort, Anna
    Castellano, Serafin
    Perez-Somarriba, Marta
    Garcia-Ariza, Miguel
    Galera, Ana
    Melwani, Kishore
    Ippolito, Hyaissa
    Rivero, Belen
    Melen, Gustavo
    Garcia-Castro, Javier
    Ramirez, Manuel
    NEURO-ONCOLOGY, 2024, 26
  • [23] PNOC015: PHASE 1 STUDY OF MTX110 DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) PREVIOUSLY TREATED WITH RADIATION THERAPY
    Mueller, Sabine
    Kline, Cassie
    Villanueva-Meyer, Javier
    Hoffman, Carly
    Raber, Shannon
    Bonner, Erin R.
    Nazarian, Javad
    Lundy, Shannon
    Molinaro, Annette
    Prados, Michael
    Filbin, Mariella
    Gupta, Nalin
    NEURO-ONCOLOGY, 2020, 22 : 66 - 66
  • [24] Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma - A North American Brain Tumor Consortium Trial
    Chang, SM
    Prados, MD
    Yung, WKA
    Fine, H
    Junck, L
    Greenberg, H
    Robins, HI
    Mehta, M
    Fink, KL
    Jaeckle, KA
    Kuhn, J
    Hess, K
    Schold, C
    CANCER, 2004, 100 (08) : 1712 - 1716
  • [25] A multi-center, randomized, double-blind phase II study comparing temozolomide (TMZ) plus either veliparib (ABT-888), a PARP inhibitor, or placebo as 2nd or 3rd-line therapy for patients (Pts) with relapsed small cell lung cancers (SCLCs).
    Pietanza, Maria Catherine
    Krug, Lee M.
    Waqar, Saiama Naheed
    Dowlati, Afshin
    Hann, Christine L.
    Chiappori, Alberto
    Owonikoko, Taofeek Kunle
    Woo, Kaitlin
    Bensman, Yevgeniya
    Hurtado, Brenda
    Fujimoto, Junya
    Wistuba, Ignacio Ivan
    Travis, William D.
    Chen, Alice P.
    Heymach, John
    Kris, Mark G.
    Fleisher, Martin
    Rudin, Charles M.
    Byers, Lauren Averett
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR AZD1775 COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217)
    Mueller, Sabine
    Yang, Xiaodong
    Pal, Sharmistha
    Ermioian, Ralph
    Fox, Elizabeth
    Gajjar, Amar
    Minard, Charles
    Liu, Xiaowei
    Prem, Komal
    Reid, Joel
    Weigel, Brenda
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2018, 20 : 201 - 201
  • [27] PNOC015: PHASE 1 STUDY OF MTX110 (AQUEOUS PANOBINOSTAT) DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) PREVIOUSLY TREATED WITH RADIATION THERAPY
    Mueller, Sabine
    Kline, Cassie
    Villanueva-Meyer, Javier
    Hoffman, Carly
    Raber, Shannon
    Bonner, Erin
    Nazarian, Javad
    Lundy, Shannon
    Molinaro, Annette M.
    Prados, Michael
    Filbin, Mariella
    Gupta, Nalin
    NEURO-ONCOLOGY, 2020, 22 : 306 - 306
  • [28] PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR ADAVOSERTIB (AZD1775) COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217)
    Mueller, Sabine
    Yang, Xiaodong
    Pal, Sharmistha
    Ermoian, Ralph
    Gajjar, Amar
    Liu, Xiaowei
    Prem, Komal
    Minard, Charles G.
    Mugundu, Ganesh
    Reid, Joel M.
    Haas-Kogan, Daphne
    Fox, Elizabeth
    Weigel, Brenda J.
    NEURO-ONCOLOGY, 2018, 20 : 284 - 284
  • [29] A PHASE 1 STUDY OF SAVOLITINIB IN RECURRENT, PROGRESSIVE, OR REFRACTORY MEDULLOBLASTOMA, HIGH-GRADE GLIOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, AND CENTRAL NERVOUS SYSTEM (CNS) TUMORS HARBORING MET ABERRATIONS: A PEDIATRIC BRAIN TUMOR CONSORTIUM TRIAL
    Salloum, Ralph
    Huang, Jie
    Stewart, Clinton F.
    Fuller, Christine
    Smolarek, Teresa
    Lenzen, Alicia
    Waanders, Angela J.
    Baxter, Patiricia
    Lindsay, Holly
    Robison, Nathan
    Pillay-Smiley, Natasha
    Partap, Sonia
    Fangusaro, Jason
    Onar-Thomas, Arzu
    Fouladi, Maryam
    Dunkel, Ira J.
    NEURO-ONCOLOGY, 2023, 25
  • [30] PHASE 1B/2 STUDY TO ASSESS THE CLINICAL EFFECTS OF PAMIPARIB (BGB-290) IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY GLIOBLASTOMA (GBM)
    Shih, Kent
    Schiff, David
    Kim, Lyndon
    Battiste, James
    Campian, Jian
    Puduvalli, Vinay
    Wen, Patrick
    Cloughesy, Timothy
    van den Bent, Martin
    Pirzkall, Andrea
    Wood, Katie
    Wei, Rachel
    Du, Bing
    Mu, Song
    Ramakrishnan, Vanitha
    Walbert, Tobias
    NEURO-ONCOLOGY, 2018, 20 : 17 - 18
1234